CymitQuimica logo

CAS 303162-79-0

:

TAK-715

Description:
TAK-715, also known by its chemical name, is a selective inhibitor of the p38 mitogen-activated protein kinase (MAPK) pathway, which plays a crucial role in inflammatory responses and cellular stress. This compound is primarily investigated for its potential therapeutic applications in treating various inflammatory diseases and conditions, including rheumatoid arthritis and other autoimmune disorders. TAK-715 exhibits a high degree of specificity for p38 MAPK, which minimizes off-target effects and enhances its efficacy in modulating inflammatory processes. The substance is typically characterized by its molecular structure, which includes specific functional groups that contribute to its biological activity. In preclinical studies, TAK-715 has demonstrated the ability to reduce pro-inflammatory cytokine production, thereby highlighting its potential as a valuable candidate in drug development aimed at managing chronic inflammatory conditions. However, as with any investigational drug, further clinical studies are necessary to fully understand its pharmacokinetics, safety profile, and therapeutic efficacy in humans.
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.